Agenda

Thursday, October 17, 2024

08:30 am EST
Welcome & Introductions

Session 1:  Histone Modifications and Chromatin Structure
Chair:  David Clark, Ph.D., National Institute of Child Health and Human Development, NIH

 

08:45 am EST
New Insights Link the Histone Methyltransferase SETD2 with Nuclear Lamina Integrity and Genome Stability

 

 

Brian Strahl, Ph.D., University of North Carolina at Chapel Hill

09:15 am EST
TBD

 

 


Shelley Berger, Ph.D., University of Pennsylvania

09:45 am EST
Molecular Insight into Epigenetic Regulatory Mechanisms Delivers Critical Targets for Cancer Therapeutics

 

 

Ali Shilatifard, Ph.D., Northwestern University

10:15 am EST
Chemical Approaches to Studying Chromatin

 

 

Tom Muir, Ph.D., Princeton University

10:45 am EST
BREAK

Session 2:  Chromatin Remodeling
Chair: Mirit Aladjem, Ph.D., Center for Cancer Research, NCI

11:00 am EST
The Biogenesis and Regulatory Dynamics of Chromatin Accessibility for Gene Expression

 

 

Carl Wu, Ph.D., Johns Hopkins University

11:30 am EST
Rewiring Cancer Drivers to Initiate Epigenetically Guarded Pathways of Programmed Cell Death

 

 

Jerry Crabtree, Ph.D., Stanford University

12:00 pm EST
Structure and Function of Mammalian SWI/SNF Chromatin Remodeling Complexes in Health and Disease

 

 

Cigall Kadoch, Ph.D., Harvard Medical School

12:30 pm EST
Genome-Wide Mapping of Chromatin Dynamics in Situ

 

 

Steve Henikoff, Ph.D., Fred Hutch Cancer Center

01:00 pm EST
LUNCH & POSTER SESSION

Session 3:  Chromatin Modifications and Gene expression
Chair: Ann Dean, Ph.D., National Institute of Diabetes and Digestive and Kidney Diseases, NIH

03:00 pm EST
Chromatin Dynamics in Cancer

 

 

Emily Bernstein, Ph.D., Icahn School of Medicine at Mount Sinai

03:30 pm EST
Epigenetic Regulation by the MSLs: Old Complex, New Facts

 

 

Asifa Akhtar, Ph.D., Max Planck Institute

04:00 pm EST
Role and Mechanism of Polycomb Silencing in Gastrulation

 

 

Yi Zhang, Ph.D., Harvard Medical School

04:30 pm EST
Epigenetic Mechanisms of Tissue Aging

 

 

Payel Sen, Ph.D., National Institute of Aging, NIH

05:00 pm EST
ADJOURN FOR THE DAY

Friday, October 18, 2024

Session 4: Chromatin Organization and Dynamics
Chair: Elissa Lei, Ph.D., National Institute of Diabetes and Digestive and Kidney Diseases, NIH

08:30 am EST
Shaping Chromatin and Cell Fate, a Choreography Involving Histones and Partners

 

 

Genevieve Almouzni, Ph.D., Curie Institute

09:00 am EST
Proximity Copy Paste (PCP): A New Method to Map the 3D Organization of Chromatin

 

 

Iestyn Whitehouse, Ph.D., Memorial Sloan Kettering Cancer Center

09:30 am EST
A Histone Methylation Writer/Reader System that Specifies the Location of Recombination

 

 

Todd Macfarlan, Ph.D., National Institute of Child Health and Human Development, NIH

10:00 am EST
Epigenetic Control of Enhancers in Cell Fate Transition and Cancer

 

 

Bing Ren, Ph.D., University of California, San Diego

10:30 am EST
Mechanism of Cohesin Localization at Enhancers

 

 

Gordon Hager, Ph.D., Center for Cancer Research, NCI

11:00 am EST
BREAK

Session 5: Histone Modifications and Development
Chair: Yamini Dalal, Ph.D. Center for Cancer Research, NCI

11:15 am EST
Human Development and Evolution Through the Gene Regulatory Lens

 

 

Joanna Wysocka, Ph.D., Stanford University

11:45 am EST
Cryo-EM Insights into the Structure and Regulation of Chromatin Modifying Complexes

 

 

Eva Nogales, Ph.D., University of California, Berkeley

12:15 pm EST
Overcoming Chromatin Barriers to Change Cell Fate

 

 

Kenneth Zaret, Ph.D., University of Pennsylvania

12:45 pm EST
How Pioneer Factors Open Chromatin in Cell Reprogramming

 

 

Yawen Bai, Ph.D., Center for Cancer Research, NCI

01:15 pm EST
LUNCH & POSTER SESSION

Session 6: Histone Modifications and Gene Silencing
Chair: Alan Hinnebusch, Ph.D., National Institute of Child Health and Human Development, NIH

03:00 pm EST
Understanding Heterochromatin Dysregulation in Childhood Cancers

 

 

Peter Lewis, Ph.D., University of Wisconsin, Madison

03:30 pm EST
New Insights into the Role of the lncRNA Xist and X-Chromosome Dosage Compensation

 

 

Kathrin Plath, Ph.D., University of California, Los Angeles

04:00 pm EST
DNA-Based Instruction for Heterochromatin Formation in the Mouse Epigenome

 

 

Thomas Jenuwein, Ph.D., Max Planck Institute

04:30 pm EST
The Molecular Basis of Heterochromatin Assembly and Epigenetic Inheritance

 

 

Shiv Grewal, Ph.D., Center for Cancer Research, NCI

05:00 pm EST
ADJOURN